Grants and Contributions:
Title:
Feasibility study: Production of a nanoparticle-encapsulated biotherapeutic for the treatment of autoimmune diseases
Agreement Number:
948505
Agreement Value:
$50,000.00
Agreement Date:
Apr 6, 2020 - Mar 31, 2021
Description:
Serenity Bioworks is conducting a feasibility study to produce the second-generation biotherapeutics for the treatment of autoimmune diseases with unmet medical needs.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Kitchener, Ontario, CA N2G 1H6
Reference Number:
172-2020-2021-Q1-948505
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
718540891
Recipient Type:
For-profit organization
Recipient's Legal Name:
Serenity Bioworks Inc.
Federal Riding Name:
Kitchener Centre
Federal Riding Number:
35045
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254